| Authors: |
Ma R; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Zhang J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Zhang MX; Peking University International Hospital, Beijing, PR China., Li Y; Peking University First Hospital, Beijing, PR China., Yin Y; Peking University First Hospital, Beijing, PR China., Wang LR; Fu Xing Hospital, Beijing, PR China., Ding L; Air Force Specialty Medical Centre, Beijing, PR China., Lou X; The Fifth Medical Centre of PLA General Hospital, Beijing, PR China., Yu YF; Peking University Shougang Hospital, Beijing, PR China., Ma L; Peking University Third Hospital, Beijing, PR China., Dou LP; The General Hospital of the People's Liberation Army, Beijing, PR China., Guo ZX; Beijing Huaxin Hospital, Beijing, PR China., Ye F; Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, PR China., Wang YN; Beijing Anzhen Hospital, Beijing, PR China., Liu Y; The Sixth Medical Centre of PLA General Hospital, Beijing, PR China., Li LH; Beijing Tsinghua Changgung Hospital, Beijing, PR China., Liu HX; Department of Clinical Epidemiology and Biostatistics, Peking University People's Hospital, PR China., Li N; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, PR China., Sun YQ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, PR China. Electronic address: sunyuqian83@hotmail.com. |
